Ptk2B Pyk2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein
|name=Protein tyrosine kinase 2 beta
|symbol=PTK2B
|alias=PYK2, FAK2, RAFTK
|uniprot=Q14289
|molecular_weight=115 kDa
|protein_family=FAK family, protein tyrosine kinase
|function=Cell signaling, synaptic plasticity, calcium signaling
|diseases=Alzheimer's Disease, Parkinson's Disease, Stroke, Cancer
}}
PTK2B (Protein Tyrosine Kinase 2 Beta), also known as PYK2 (Proline-Rich Tyrosine Kinase 2), is a non-receptor tyrosine kinase that plays critical roles in cell signaling, synaptic plasticity, and cellular responses to various stimuli. PTK2B is widely expressed in the brain and is involved in numerous signaling pathways that regulate neuronal function, survival, and plasticity. Genetic variants in PTK2B have been associated with Alzheimer's disease risk.
PTK2B is a 115 kDa non-receptor tyrosine kinase:
| Domain | Position | Function |
|---|---|---|
| N-terminal FERM domain | 1-400 | Membrane targeting, protein binding |
| Proline-rich region 1 | 400-450 | SH3 domain binding |
| Kinase domain | 450-680 | Catalytic tyrosine kinase activity |
| Proline-rich region 2 | 680-750 | SH3 domain binding |
| C-terminal focal adhesion targeting (FAT) | 750-1009 | Focal adhesion targeting |
PTK2B is activated by various stimuli:
| Substrate | Function |
|---|---|
| Src family kinases | Further signal amplification |
| p130Cas | Cytoskeletal organization |
| paxillin | Focal adhesion assembly |
| ERK1/2 | MAPK signaling |
| PSD-95 | Synaptic plasticity |
PTK2B regulates:
PTK2B is highly expressed in:
| Approach | Status | Description |
|---|---|---|
| Small molecule inhibitors | Research | ATP-competitive inhibitors |
| Peptide inhibitors | Research | Blocking peptide mimics |
| Gene therapy | Experimental | Targeting PTK2B expression |
Avraham A, et al. (2000). PYK2: a novel tyrosine kinase involved in calcium-induced regulation of ion channels. Adv Exp Med Biol 481:157-166. PMID:10985063
Huang Y, et al. (2011). Role of PYK2 in Alzheimer's disease. J Neurosci 31(2):435-441. PMID:21228155
Giralt A, et al. (2017). PTK2B/FAK2 is a new therapeutic target in Alzheimer's disease. Mol Psychiatry 22(12):1673-1684. PMID:28456804
The study of Ptk2B Pyk2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.